These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11337909)

  • 1. Hoechst 33342-induced apoptosis is associated with decreased immunoreactive topoisomerase I and topoisomerase I-DNA complex formation.
    Zhang X; Kiechle F
    Ann Clin Lab Sci; 2001 Apr; 31(2):187-98. PubMed ID: 11337909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hoechst 33342-induced apoptosis is associated with intracellular accumulation of E2F-1 protein in BC3H-1 myocytes and HL-60 cells.
    Zhang X; Kiechle FL
    Arch Pathol Lab Med; 2001 Jan; 125(1):99-104. PubMed ID: 11151061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo.
    Zhang X; Chen J; Davis B; Kiechle F
    Arch Pathol Lab Med; 1999 Oct; 123(10):921-7. PubMed ID: 10506445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hoechst 33342 induces apoptosis and alters tata box binding protein/DNA complexes in nuclei from BC3H-1 myocytes.
    Zhang X; Kiechle FL
    Biochem Biophys Res Commun; 1998 Jul; 248(1):18-21. PubMed ID: 9675078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of topoisomerases in cytotoxicity induced by DNA ligand Hoechst-33342 and UV-C in a glioma cell line.
    Singh S; Dwarakanath BS; Lazar Mathew T
    Indian J Exp Biol; 2005 Apr; 43(4):313-23. PubMed ID: 15875714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Hoechst 33342-induced apoptosis in BC3H-1 myocytes.
    Zhang X; Kiechle FL
    Ann Clin Lab Sci; 1998; 28(2):104-14. PubMed ID: 9558449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hoechst 33342-induced apoptosis in BC3H-1 myocytes.
    Zhang X; Kiechle FL
    Ann Clin Lab Sci; 1997; 27(4):260-75. PubMed ID: 9210971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures.
    Chen AY; Yu C; Bodley A; Peng LF; Liu LF
    Cancer Res; 1993 Mar; 53(6):1332-7. PubMed ID: 8383008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
    Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
    Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
    Li G; Tolstonog GV; Sabasch M; Traub P
    DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
    Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
    Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hoechst 33342 alters luciferase gene expression in transfected BC3H-1 myocytes.
    Zhang X; Kiechle FL
    Arch Pathol Lab Med; 2003 Sep; 127(9):1124-32. PubMed ID: 12946233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ligands as radioprotectors: molecular studies with Hoechst 33342 and Hoechst 33258.
    Denison L; Haigh A; D'Cunha G; Martin RF
    Int J Radiat Biol; 1992 Jan; 61(1):69-81. PubMed ID: 1370318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of topoisomerase I purified from avian erythrocytes.
    Trask DK; Muller MT
    Nucleic Acids Res; 1983 May; 11(9):2779-800. PubMed ID: 6304657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ligand Hoechst-33342 enhances UV induced cytotoxicity in human glioma cell lines.
    Singh S; Dwarakanath BS; Mathew TL
    J Photochem Photobiol B; 2004 Dec; 77(1-3):45-54. PubMed ID: 15542361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribonuclease activity of vaccinia DNA topoisomerase IB: kinetic and high-throughput inhibition studies using a robust continuous fluorescence assay.
    Kwon K; Nagarajan R; Stivers JT
    Biochemistry; 2004 Nov; 43(47):14994-5004. PubMed ID: 15554707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene.
    Stewart AF; Schütz G
    Cell; 1987 Sep; 50(7):1109-17. PubMed ID: 2887294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA topoisomerase V is a relative of eukaryotic topoisomerase I from a hyperthermophilic prokaryote.
    Slesarev AI; Stetter KO; Lake JA; Gellert M; Krah R; Kozyavkin SA
    Nature; 1993 Aug; 364(6439):735-7. PubMed ID: 8395022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.